These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 4978461

  • 1. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract] [Full Text] [Related]

  • 2. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E, Rózewska M.
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K, Kudo S, Iwai K, Ushikubo K.
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract] [Full Text] [Related]

  • 4. [Capreomycin in the combination treatment of chronic pulmonary tuberculosis].
    Sighart H, Opl G.
    Prax Pneumol; 1970 Jan; 24(1):15-20. PubMed ID: 4984503
    [No Abstract] [Full Text] [Related]

  • 5. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA.
    Scand J Respir Dis Suppl; 1968 Jan; 65():147-50. PubMed ID: 4978458
    [No Abstract] [Full Text] [Related]

  • 6. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H, Maekawa N, Nakanishi M, Kawai M, Naito M.
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG.
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative bacteriology in the clinical testing of new antituberculosis drugs.
    Wallace AT.
    Tubercle; 1969 Mar; 50():Suppl:47-9. PubMed ID: 4990183
    [No Abstract] [Full Text] [Related]

  • 9. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB, Klimenko MT.
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract] [Full Text] [Related]

  • 11. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A, Gogate A.
    Indian J Public Health; 1998 Oct; 42(4):126-30. PubMed ID: 10389525
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
    Vinik LK, Konjicija A, Sutić N, Psorn-Rajs A, Matić M, Arslanagić N.
    Plucne Bolesti; 1988 Oct; 40(1-2):32-5. PubMed ID: 3141940
    [No Abstract] [Full Text] [Related]

  • 13. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972 Oct; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 14. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI, Grishina TA, Karpenko OL, Safonova SG, Grishina TD.
    Probl Tuberk; 1995 Oct; (4):37-40. PubMed ID: 7567869
    [Abstract] [Full Text] [Related]

  • 15. Clinical application of capreomycin in pulmonary tuberculosis.
    Zierski M, Bek E.
    Pol Med J; 1970 Oct; 9(3):652-60. PubMed ID: 5452842
    [No Abstract] [Full Text] [Related]

  • 16. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F.
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract] [Full Text] [Related]

  • 17. [Possibility of the intensification of tuberculosis chemotherapy and its limits].
    Naito M, Kanai K, Kondo E, Yamashita H, Matsui K.
    Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative bacteriological study of sputum and resected lung particles in patients with tuberculosis].
    Fisher EF, Gaĭnutdinova NSh, Liadunkina MM, Mulik MI.
    Lab Delo; 1969 Nov; 5():298-300. PubMed ID: 4185264
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on the origin and clinical significance of smear-positive and culture-negative tubercle bacilli].
    Tsukamura M, Toyama H.
    Kekkaku; 1984 Aug; 59(8):451-9. PubMed ID: 6438383
    [No Abstract] [Full Text] [Related]

  • 20. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
    Virchow C, Flemming J.
    Beitr Klin Erforsch Tuberk Lungenkr; 1969 Aug; 140(1):40-6. PubMed ID: 5824389
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.